AMSSM position statement update: blood-borne pathogens in the context of sports participation
Author
McGrew, ChristopherMacCallum, Daisy-Scarlett
Narducci, Dustymarie
Nuti, Rathna
Calabrese, Leonard
Dimeff, Robert J
Paul, Stephen
Poddar, Sourav
Rao, Ashwin
McKeag, Douglas
Affiliation
Univ Arizona, Dept Family & Community MedIssue Date
2019-03-19
Metadata
Show full item recordPublisher
BMJ PUBLISHING GROUPCitation
McGrew C, MacCallum D-S, Narducci D, et al. Br J Sports Med 2020; 54:200–207.Rights
Copyright © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
This American Medical Society for Sports Medicine position statement update is directed towards healthcare providers of patients involved in sport and exercise. There have been significant advances in clinical and scientific research in the understanding of blood-borne pathogens (BBPs), and this update incorporates these advancements. This document is intended as a general guide to clinical practice based on the current state of the evidence, while acknowledging the need for modification as new knowledge becomes available. Confirmed transmission of BBPs during sport is exceedingly rare. There are no well-documented reports of HIV, HCV or HDV transmission during sport. There is also no evidence for universal testing for BBPs as a specific requirement for participation in sports. Competitive athletes and non-athletes should follow appropriate general public health agency recommendations for screening for BBPs, considering their individual risk factors and exposures. Standard (universal) precautions must be followed by those providing care to athletes. Exercise and athletic participation can help promote a healthy lifestyle for persons living with BBPs. Those with acute symptomatic BBP infection should limit exercise intensity based on their current health status. Education is the key tool for preventing BBP transmission. Research gaps include evaluation of the prevalence of BBP infections in competitive athletes, the effects of long-term, intense training on infected athletes and the effects of BBP treatment therapies on performance.ISSN
0306-3674PubMed ID
30890535Version
Final published versionae974a485f413a2113503eed53cd6c53
10.1136/bjsports-2019-100650
Scopus Count
Collections
Related articles
- AMSSM Position Statement Update: Blood-Borne Pathogens in the Context of Sports Participation.
- Authors: McGrew C, MacCallum DS, Narducci D, Nuti R, Calabrese L, Dimeff R, Paul S, Poddar SK, Rao A, McKeag D
- Issue date: 2020 Jul
- AMSSM Position Statement on Cardiovascular Preparticipation Screening in Athletes: Current Evidence, Knowledge Gaps, Recommendations and Future Directions.
- Authors: Drezner JA, O'Connor FG, Harmon KG, Fields KB, Asplund CA, Asif IM, Price DE, Dimeff RJ, Bernhardt DT, Roberts WO
- Issue date: 2016 Sep-Oct
- AMSSM Position Statement on Cardiovascular Preparticipation Screening in Athletes: Current evidence, knowledge gaps, recommendations and future directions.
- Authors: Drezner JA, O'Connor FG, Harmon KG, Fields KB, Asplund CA, Asif IM, Price DE, Dimeff RJ, Bernhardt DT, Roberts WO
- Issue date: 2017 Feb
- Perceived knowledge of blood-borne pathogens and avoidance of contact with infected patients.
- Authors: Kagan I, Ovadia KL, Kaneti T
- Issue date: 2009 Mar
- AMSSM Position Statement on Cardiovascular Preparticipation Screening in Athletes: Current Evidence, Knowledge Gaps, Recommendations, and Future Directions.
- Authors: Drezner JA, OʼConnor FG, Harmon KG, Fields KB, Asplund CA, Asif IM, Price DE, Dimeff RJ, Bernhardt DT, Roberts WO
- Issue date: 2016 Sep